Entera Bio ENTX
NASDAQ ENTX
$2.69 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Entera Bio (ENTX) FCF Margin (2021 - 2025)

Updated

Entera Bio (ENTX) posted FCF Margin of -17802.38% for FY2025, down 14033.87 percentage points from -3768.51% in FY2024.

Analysis

Entera Bio (ENTX) FCF Margin (2021 - 2025) Analysis & Trends

Since FY2018, Entera Bio has reported FCF Margin for 6 years.

  • Annual FCF Margin shows a five-year change of -14895.53 percentage points (FY2020 to FY2025).
  • The FY2025 figure stands as the lowest annual FCF Margin in data going back to FY2018.
  • Business Quant data shows ENTX's FCF Margin at -3768.51% in FY2024, -9362.69% in FY2022 (-7772.49 pp) and -1590.19% in FY2021 (+1316.66 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Entera Bio 132.59 Mn 101.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -3,361.90%
Dec 31, 2024 -1,792.68%
Sep 30, 2024 -5,128.57%
Jun 30, 2024 -2,342.11%
Dec 31, 2022 -14,385.71%
Sep 30, 2022 -35,887.50%
Jun 30, 2022 -6,468.18%
Mar 31, 2022 -7,080.88%
Dec 31, 2021 -1,528.48%
Sep 30, 2021 -1,511.43%
Jun 30, 2021 -1,945.87%
Mar 31, 2021 -1,478.34%
API Access

Entera Bio FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ENTX&period=max&api_key=YOUR_API_KEY